Clinical Trial Update: Median Effective Dose of Remimazolam for Sedation in Elderly Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial reporting the median effective dose of remimazolam for sedation in elderly patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sedative

Drugs mentioned

• Remimazolam (remimazolam)

Snippet

Sponsor: Asan Medical Center | Conditions: Sedative | Phase 4 | Status: COMPLETED